Dr. Mortazavi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
460 W 10th Ave
Columbus, OH 43210Phone+1 614-293-6529Fax+1 614-293-9469
Education & Training
- Ohio State University HospitalFellowship, Hematology and Medical Oncology, 2006
- University at BuffaloResidency, Internal Medicine, 2000 - 2003
- Tehran University of Medical Sciences School of MedicineClass of 1997
Certifications & Licensure
- CA State Medical License 2024 - 2026
- OH State Medical License 2003 - 2026
- FL State Medical License 2019 - 2022
- PA State Medical License Active through 2012
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Axitinib With or Without Anti-OX40 Antibody PF-04518600 in Treating Patients With Metastatic Kidney Cancer Start of enrollment: 2017 Jul 19
Publications & Presentations
PubMed
- 11 citationsCabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy.Daniel M Girardi, Scot A Niglio, Amir Mortazavi, Rosa Nadal, Primo Lara
Clinical Cancer Research. 2022-04-01 - 1 citationsA Phase 2 Study of Sitravatinib in Combination with Nivolumab in Patients with Advanced or Metastatic Urothelial Carcinoma.Pavlos Msaouel, Randy F Sweis, Manojkumar Bupathi, Elisabeth Heath, Oscar B Goodman Jr
European Urology Oncology. 2024-08-01 - 29 citationsNeoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial.Samuel A Funt, Michael Lattanzi, Karissa Whiting, Hikmat Al-Ahmadie, Colleen Quinlan
Journal of Clinical Oncology. 2022-04-20
Professional Memberships
- Member
Other Languages
- Farsi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: